Skip to main content
SpringerLink
Log in

Antiretroviral news from the 9th ICDTHI

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Simpson KN, Dietz B, Rahim SX, Rajagopalan R.Cost-effectiveness of switching to second-line therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda. 9th International Congress on Drug Therapy in HIV Infection: abstr. P307, 9 Nov 2008. Available from: URL: http://www.hiv9.com

  2. Arribas JR, Pulido F, Méndez I, Lázaro P, Norton M, Cabrero E, Burgos A.96 Weeks pharmacoeconomic outcome of lopinavir/r monotherapy as maintenance strategy in HIV+ patients with suppressed viral load. OK04-PharmECO analysis. 9th International Congress on Drug Therapy in HIV Infection: abstr. P308, 9 Nov 2008. Available from: URL: http://www.hiv9.com

  3. Simpson KN, Rajagopalan R, Dietz B.Cost-effectiveness and budget impact of lopinavir/ritonavir and atazanavir plus ritonavir regimens based on 48-week results from the CASTLE study. 9th International Congress on Drug Therapy in HIV Infection: abstr. P311, 9 Nov 2008. Available from: URL: http://www.hiv9.com

  4. Moeremans K, Hemmett LC, Hjelmgren J, Allegri G, Smets E.Cost-effectiveness of DRV/r 600/100 mg BID in treatment-experienced, LPV/r-naive, PI-resistant, HIV-infected adults in the UK, Belgium, Italy and Sweden. 9th International Congress on Drug Therapy in HIV Infection: abstr. P313, 9 Nov 2008. Available from: URL: http://www.hiv9.com

  5. Elbasha E, Dunlop W, Chaudhary MA, Kumar RN.An economic evaluation of using raltegravir in treatment-experienced HIV-1 infected patients in the UK 9th International Congress on Drug Therapy in HIV Infection: abstr. P310, 9 Nov 2008. Available from: URL: http://www.hiv9.com

  6. Lekander I, Berg J, Christie A, Leen C, Nelson M.A cost-effectiveness analysis of Maraviroc in treatment-experienced HIV patients in Scotland. 9th International Congress on Drug Therapy in HIV Infection: abstr. P315, 9 Nov 2008. Available from: URL: http://www.hiv9.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antiretroviral news from the 9th ICDTHI. Pharmacoecon. Outcomes News 569, 4–5 (2009). https://doi.org/10.2165/00151234-200905690-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905690-00010

Keywords

Search

Navigation